Keynote speaker
Vice President, Head of Clinical Development, Rivus Pharmaceuticals
Stefanie Mason, Vice President, Head of Clinical Development at Rivus Pharmaceuticals, gave a keynote at 10th MASH Drug Development Summit 2026 (Boston, United States of America, 15–17 Sept 2026) in the session “Leveraging an Energy Expenditure Mechanism to Drive Liver-Targeted Reductions in Fat and Inflammation, the Primary Drivers of MASH”.
15–17 Sept 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Senior Director, Cellarity
Faculty, Harvard Medical School and Mass General Brigham
Associate Director, Clinical Research, Akero Therapeutics
Vice President, Discovery Biology, Sepia Therapeutics
Scientific Director & Associate Research Fellow, Pfizer
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Stefanie Mason, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].